178 related articles for article (PubMed ID: 32325489)
1. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.
Meissner B; Kridel R; Lim RS; Rogic S; Tse K; Scott DW; Moore R; Mungall AJ; Marra MA; Connors JM; Steidl C; Gascoyne RD
Blood; 2013 Apr; 121(16):3161-4. PubMed ID: 23407552
[TBL] [Abstract][Full Text] [Related]
3. The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.
Muñoz-Escobar J; Matta-Camacho E; Kozlov G; Gehring K
J Biol Chem; 2015 Sep; 290(37):22841-50. PubMed ID: 26224628
[TBL] [Abstract][Full Text] [Related]
4. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
5. Structure of the HECT C-lobe of the UBR5 E3 ubiquitin ligase.
Matta-Camacho E; Kozlov G; Menade M; Gehring K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1158-63. PubMed ID: 23027739
[TBL] [Abstract][Full Text] [Related]
6. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
7. Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5.
Hodáková Z; Grishkovskaya I; Brunner HL; Bolhuis DL; Belačić K; Schleiffer A; Kotisch H; Brown NG; Haselbach D
EMBO J; 2023 Aug; 42(16):e113348. PubMed ID: 37409633
[TBL] [Abstract][Full Text] [Related]
8. UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.
Xiang G; Wang S; Chen L; Song M; Song X; Wang H; Zhou P; Ma X; Yu J
Cell Death Dis; 2022 May; 13(5):451. PubMed ID: 35551175
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human UBR5 E3 ubiquitin ligase.
Wang F; He Q; Zhan W; Yu Z; Finkin-Groner E; Ma X; Lin G; Li H
Structure; 2023 May; 31(5):541-552.e4. PubMed ID: 37040767
[TBL] [Abstract][Full Text] [Related]
10. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.
Saez I; Gerbracht JV; Koyuncu S; Lee HJ; Horn M; Kroef V; Denzel MS; Dieterich C; Gehring NH; Vilchez D
FEBS Lett; 2020 Jan; 594(1):175-188. PubMed ID: 31365120
[TBL] [Abstract][Full Text] [Related]
12. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
14. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
15. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
16. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interaction and ubiquitination of phosphoenolpyruvate carboxykinase by E3 ligase UBR5.
Shen Q; Qiu Z; Wu W; Zheng J; Jia Z
Biol Open; 2018 Dec; 7(12):. PubMed ID: 30552140
[TBL] [Abstract][Full Text] [Related]
18. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
19. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
20.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
